Eli Lilly and Company
893 S Delaware St
Indianapolis
Indiana
46285
United States
About Eli Lilly and Company
Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.
Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly
3430 articles about Eli Lilly and Company
-
FDA Staff: Adult Antidepressant Risks Differ By Age
12/6/2006
-
The International Diabetes Federation And Eli Lilly and Company Partner To Uncover Practical Solutions For Better Diabetes Outcomes
12/5/2006
-
Eli Lilly and Company To Take $100-$110 Million Plant Closing Charge
12/1/2006
-
Eli Lilly and Company Responds To The Cost-Effectiveness Analysis Of The CATIE Schizophrenia Trial
12/1/2006
-
VisEn Medical Establishes Program To Develop And Apply Fluorescence In Vivo Imaging Technologies In Pharmaceutical R&D
11/29/2006
-
Webcast Alert: Applied NeuroSolutions, Inc. Announces Its Conference Call To Discuss Agreement With Eli Lilly and Company Webcast
11/28/2006
-
Applied NeuroSolutions, Inc. Announces Agreement With Eli Lilly and Company To Develop Therapeutics To Treat Alzheimer's Disease
11/28/2006
-
Eli Lilly and Company Release: BYETTA(R) (exenatide) Approved For Treatment Of Type 2 Diabetes By European Commission
11/21/2006
-
Eli Lilly and Company Foundation To Fund World-Class Diabetes Treatment And Care Program At Riley Hospital For Children
11/13/2006
-
Lipid Sciences, Inc. Enters Into Collaborative Research And License Agreement With Elanco Animal Health Division Of Eli Lilly and Company For Development Of Animal Health Products
11/8/2006
-
Duloxetine Effective For Diabetic Neuropathic Pain
10/30/2006
-
Study Suggests Eli Lilly and Company's Strattera(R) Was Effective In Treating ADHD In Children And Adolescents With ADHD And Reading Disorders
10/27/2006
-
Eli Lilly and Company Release: New Study Shows Prasugrel Achieves Faster Onset And Higher Levels Of Platelet Inhibition Than Clopidogrel At Approved Or Higher Doses
10/24/2006
-
The Week In Review: Biotech Goes Four For Four
10/23/2006
-
Eli Lilly and Company Launches Phase III 'GALES' Trial Of ALIMTA(R) (Pemetrexed for Injection) In Small Cell Lung Cancer
10/20/2006
-
National Institutes of Health (NIH): Eli Lilly and Company Influenced Sepsis Treatment
10/19/2006
-
In Response To A Letter To The Editor That Appears In The Oct. 19, 2006, Issue Of The New England Journal of Medicine, Eli Lilly and Company Provides The Following Statement:
10/19/2006
-
Eli Lilly and Company Reports 7% Sales Growth, 10% Earnings Growth And $.80 EPS For Third Quarter
10/19/2006
-
The Day In Review: Rampant Deal Activity In Biotech
10/17/2006
-
Eli Lilly and Company To Acquire ICOS Corporation For $2.1 Billion
10/17/2006